LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10138-1 | Ruxolitinib | LSM-1139 |  | 25126798 | |
| 10135-1 | Linsitinib | OSI 906 | LSM-1135 |  | 11640390 |
| 10134-1 | GSK1904529A | LSM-1134 |  | 25124816 | |
| 10133-1 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10132-1 | SNS-032 | BMS-387032 | LSM-1132 |  | 3025986 |
| 10128-1 | GSK 690693 | LSM-1128 |  | 16048642 | |
| 10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 |  | 49830557 |
| 10126-1 | PI103 | LSM-1126 |  | 9884685 | |
| 10125-1 | PHA-665752 | LSM-42793 |  | 66596670 | |
| 10122-1 | NVP-AEW541 | AEW541 | LSM-44953 |  | 11476171 |
| 10120-1 | Canertinib | CI-1033; PD-183805 | LSM-1120 |  | 156414 |
| 10119-1 | SU11274 | PKI-SU11274 | LSM-42791 |  | 53396327 |
| 10117-1 | Celastrol | LSM-1117 |  | 5315765 | |
| 10116-1 | PF431396 | LSM-1116 |  | 11598628 | |
| 10115-1 | LDN-193189 | DM 3189 | LSM-1115 |  | 25195294 |
| 10112-1 | PF477736 | LSM-1112 |  | 16750408 | |
| 10111-1 | TWS119 | LSM-1111 |  | 9549289 | |
| 10109-1 | YM 201636 | Kin001-170 | LSM-1109 |  | 9956222 |
| 10108-1 | Geldanamycin | LSM-42789 |  | 644250 | |
| 10101-1 | PD0325901 | PD-325901 | LSM-1101 |  | 9826528 |
| 10100-1 | JNK-9L | KIN001-204 | LSM-36386 |  | 25222038 |
| 10099-1 | Nilotinib | AMN-107 | LSM-1099 |  | 644241 |
| 10098-1 | Gefitinib | ZD1839; Iressa | LSM-1098 |  | 123631 |
| 10097-1 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10091-1 | XMD16-144 | LSM-43287 |  |